STRATA CRITICAL MEDICAL, INC. (SRTA) Free cash flow 2019–2025
STRATA CRITICAL MEDICAL, INC. (SRTA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$58.5MFY2025 · since FY2019: -$10.9M → -$58.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$58.5M | -75.3% |
| FY2024 | -$33.4M | +3.1% |
| FY2023 | -$34.5M | +9.0% |
| FY2022 | -$37.9M | -137.9% |
| FY2021 | -$15.9M | -1258.3% |
| FY2020 | -$1.2M | +89.3% |
| FY2019 | -$10.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More SRTA financial trends
SRTA RevenueSRTA Net incomeSRTA Net marginSRTA Gross profitSRTA Gross marginSRTA Operating incomeSRTA Operating marginSRTA Operating cash flowSRTA Capital expendituresSRTA Return on equitySRTA Stock buybacksSRTA Dividends paidSRTA Total assetsSRTA Total liabilitiesSRTA Shareholders’ equitySRTA overview →